TDF/FTC作为PrEP用药具有良好的安全性和耐受性。在PrEP刚开始的4周内，有少部分个体服药后可能会出现轻度的恶心、头痛、体重减轻或其他症状，但大多数症状在之后4周内会消失或缓解[1]。

The target for MSCI China was also raised by 9 percent. Morgan Stanley forecasted a larger exposure to the Internet and tech in the Hong Kong market. "The A-share market does not have Internet ...